Go Pro

MarketBeat Instant News Alerts

Lamar Advertising logo with Real Estate background

Wells Fargo & Company Issues Positive Forecast for Lamar Advertising (NASDAQ:LAMR) Stock Price

Wells Fargo & Company boosted their price objective on Lamar Advertising from $150.00 to $151.00 and gave the stock an "equal weight" rating in a research note on Wednesday.

NASDAQ:LAMR
Read Wells Fargo & Company Issues Positive Forecast for Lamar Advertising (NASDAQ:LAMR) Stock Price
Bicara Therapeutics logo with Healthcare background

Wells Fargo & Company Boosts Bicara Therapeutics (NASDAQ:BCAX) Price Target to $23.00

Wells Fargo & Company upped their price target on Bicara Therapeutics from $16.00 to $23.00 and gave the company an "equal weight" rating in a report on Wednesday.

NASDAQ:BCAX
Read Wells Fargo & Company Boosts Bicara Therapeutics (NASDAQ:BCAX) Price Target to $23.00
Claritev logo with Healthcare background

Claritev (NYSE:CTEV) Price Target Raised to $30.00

Wells Fargo & Company raised their target price on shares of Claritev from $22.00 to $30.00 and gave the stock an "equal weight" rating in a research note on Wednesday.

NYSE:CTEV
Read Claritev (NYSE:CTEV) Price Target Raised to $30.00
Cardinal Health logo with Healthcare background

Wells Fargo & Company Forecasts Strong Price Appreciation for Cardinal Health (NYSE:CAH) Stock

Wells Fargo & Company boosted their price target on Cardinal Health from $245.00 to $277.00 and gave the company an "overweight" rating in a research note on Wednesday.

NYSE:CAH
Read Wells Fargo & Company Forecasts Strong Price Appreciation for Cardinal Health (NYSE:CAH) Stock
Septerna logo with Healthcare background

Septerna (NASDAQ:SEPN) Price Target Raised to $50.00 at Wells Fargo & Company

Wells Fargo & Company lifted their price target on Septerna from $48.00 to $50.00 and gave the company an "overweight" rating in a report on Wednesday.

NASDAQ:SEPN
Read Septerna (NASDAQ:SEPN) Price Target Raised to $50.00 at Wells Fargo & Company
Crescent Capital BDC logo with Finance background

Crescent Capital BDC (NASDAQ:CCAP) Price Target Lowered to $11.00 at Wells Fargo & Company

Wells Fargo & Company dropped their price target on shares of Crescent Capital BDC from $12.00 to $11.00 and set an "equal weight" rating on the stock in a research report on Wednesday.

NASDAQ:CCAP
Read Crescent Capital BDC (NASDAQ:CCAP) Price Target Lowered to $11.00 at Wells Fargo & Company

Trending News

All MarketBeat Instant News Alerts

Bain Capital Specialty Finance logo with Finance background

Wells Fargo & Company Has Lowered Expectations for Bain Capital Specialty Finance (NYSE:BCSF) Stock Price

NYSE:BCSF
Read Wells Fargo & Company Has Lowered Expectations for Bain Capital Specialty Finance (NYSE:BCSF) Stock Price
Venture Global logo with Energy background

Venture Global (NYSE:VG) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

NYSE:VG
Read Venture Global (NYSE:VG) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Excelerate Energy logo with Energy background

Excelerate Energy (NYSE:EE) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

NYSE:EE
Read Excelerate Energy (NYSE:EE) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Flutter Entertainment logo with Consumer Discretionary background

Flutter Entertainment (NYSE:FLUT) Now Covered by JPMorgan Chase & Co.

NYSE:FLUT
Read Flutter Entertainment (NYSE:FLUT) Now Covered by JPMorgan Chase & Co.
Super Micro Computer logo with Technology background

Rosenblatt Securities Boosts Super Micro Computer (NASDAQ:SMCI) Price Target to $51.00

NASDAQ:SMCI
Read Rosenblatt Securities Boosts Super Micro Computer (NASDAQ:SMCI) Price Target to $51.00
Lumentum logo with Technology background

Lumentum (NASDAQ:LITE) Earns "Buy" Rating from Rosenblatt Securities

NASDAQ:LITE
Read Lumentum (NASDAQ:LITE) Earns "Buy" Rating from Rosenblatt Securities
CoreWeave logo with Technology background

CoreWeave's (CRWV) Buy Rating Reaffirmed at Rosenblatt Securities

NASDAQ:CRWV
Read CoreWeave's (CRWV) Buy Rating Reaffirmed at Rosenblatt Securities
Quantinuum logo with Technology background

Rosenblatt Securities Reaffirms "Buy" Rating for Quantinuum (NASDAQ:QNT)

NASDAQ:QNT
Read Rosenblatt Securities Reaffirms "Buy" Rating for Quantinuum (NASDAQ:QNT)
LB Pharmaceuticals logo with Healthcare background

BMO Capital Markets Increases LB Pharmaceuticals (NASDAQ:LBRX) Price Target to $54.00

NASDAQ:LBRX
Read BMO Capital Markets Increases LB Pharmaceuticals (NASDAQ:LBRX) Price Target to $54.00
Septerna logo with Healthcare background

Septerna (NASDAQ:SEPN) Price Target Raised to $60.00

NASDAQ:SEPN
Read Septerna (NASDAQ:SEPN) Price Target Raised to $60.00
QuickLogic logo with Technology background

QuickLogic (NASDAQ:QUIK) Price Target Cut to $20.00 by Analysts at Needham & Company LLC

NASDAQ:QUIK
Read QuickLogic (NASDAQ:QUIK) Price Target Cut to $20.00 by Analysts at Needham & Company LLC
Omada Health logo with Healthcare background

Omada Health (NASDAQ:OMDA) Given New $25.00 Price Target at Robert W. Baird

NASDAQ:OMDA
Read Omada Health (NASDAQ:OMDA) Given New $25.00 Price Target at Robert W. Baird
Quantinuum logo with Technology background

Quantinuum (NASDAQ:QNT) Given Overweight Rating at Cantor Fitzgerald

NASDAQ:QNT
Read Quantinuum (NASDAQ:QNT) Given Overweight Rating at Cantor Fitzgerald
ServiceTitan logo with Technology background

ServiceTitan (NASDAQ:TTAN) Given New $101.00 Price Target at Robert W. Baird

NASDAQ:TTAN
Read ServiceTitan (NASDAQ:TTAN) Given New $101.00 Price Target at Robert W. Baird
Quantinuum logo with Technology background

Needham & Company LLC Reaffirms Buy Rating for Quantinuum (NASDAQ:QNT)

NASDAQ:QNT
Read Needham & Company LLC Reaffirms Buy Rating for Quantinuum (NASDAQ:QNT)
Vera Therapeutics logo with Healthcare background

Vera Therapeutics (NASDAQ:VERA) Given New $90.00 Price Target at HC Wainwright

NASDAQ:VERA
Read Vera Therapeutics (NASDAQ:VERA) Given New $90.00 Price Target at HC Wainwright
Neurogene logo with Healthcare background

HC Wainwright Issues Pessimistic Forecast for Neurogene (NASDAQ:NGNE) Stock Price

NASDAQ:NGNE
Read HC Wainwright Issues Pessimistic Forecast for Neurogene (NASDAQ:NGNE) Stock Price
VinFast Auto logo with Consumer Discretionary background

Chardan Capital Reaffirms Buy Rating for VinFast Auto (NASDAQ:VFS)

NASDAQ:VFS
Read Chardan Capital Reaffirms Buy Rating for VinFast Auto (NASDAQ:VFS)
NEXT logo with Consumer Discretionary background

NEXT (LON:NXT) Insider Jeni Mundy Acquires 160 Shares

LON:NXT
Read NEXT (LON:NXT) Insider Jeni Mundy Acquires 160 Shares
Mobia Medical logo with Healthcare background

BTIG Research Reaffirms Buy Rating for Mobia Medical (NASDAQ:MOBI)

NASDAQ:MOBI
Read BTIG Research Reaffirms Buy Rating for Mobia Medical (NASDAQ:MOBI)
Maze Therapeutics logo with Healthcare background

Maze Therapeutics (NASDAQ:MAZE) Earns "Buy" Rating from BTIG Research

NASDAQ:MAZE
Read Maze Therapeutics (NASDAQ:MAZE) Earns "Buy" Rating from BTIG Research
LightPath Technologies logo with Technology background

Piper Sandler Initiates Coverage on LightPath Technologies (NASDAQ:LPTH)

NASDAQ:LPTH
Read Piper Sandler Initiates Coverage on LightPath Technologies (NASDAQ:LPTH)
Intuitive Surgical logo with Healthcare background

Intuitive Surgical (NASDAQ:ISRG) Rating Increased to Outperform at Oppenheimer

NASDAQ:ISRG
Read Intuitive Surgical (NASDAQ:ISRG) Rating Increased to Outperform at Oppenheimer
Innate Pharma logo with Healthcare background

BTIG Research Issues Positive Forecast for Innate Pharma (NASDAQ:IPHA) Stock Price

NASDAQ:IPHA
Read BTIG Research Issues Positive Forecast for Innate Pharma (NASDAQ:IPHA) Stock Price

Featured Articles and Offers

Alert Categories

All Alerts